[go: up one dir, main page]

TN2010000390A1 - Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease - Google Patents

Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease

Info

Publication number
TN2010000390A1
TN2010000390A1 TNP2010000390A TN2010000390A TN2010000390A1 TN 2010000390 A1 TN2010000390 A1 TN 2010000390A1 TN P2010000390 A TNP2010000390 A TN P2010000390A TN 2010000390 A TN2010000390 A TN 2010000390A TN 2010000390 A1 TN2010000390 A1 TN 2010000390A1
Authority
TN
Tunisia
Prior art keywords
treatment
formula
tyrosine kinase
mediated disease
imidazo
Prior art date
Application number
TNP2010000390A
Other languages
French (fr)
Inventor
Pascal Furet
Clive Mccarthy
Joseph Schoepfer
Carsten Spanka
Melanie Stang
Frederic Stauffer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/052302 external-priority patent/WO2009106577A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2010000390A1 publication Critical patent/TN2010000390A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to compounds of formula (I) and salts thereof, formula (I) wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharamaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
TNP2010000390A 2009-02-26 2010-08-25 Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease TN2010000390A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/052302 WO2009106577A1 (en) 2008-02-28 2009-02-26 Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease

Publications (1)

Publication Number Publication Date
TN2010000390A1 true TN2010000390A1 (en) 2011-12-29

Family

ID=55024512

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000390A TN2010000390A1 (en) 2009-02-26 2010-08-25 Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease

Country Status (1)

Country Link
TN (1) TN2010000390A1 (en)

Similar Documents

Publication Publication Date Title
MX2010009414A (en) Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease.
IN2012DN01453A (en)
MX2012001838A (en) Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation.
MX2014003194A (en) 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase.
MY187131A (en) Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
MX2012001529A (en) 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators.
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
JO3265B1 (en) Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease
TN2012000249A1 (en) Pyrazine derivatives and their use in the treatment of neurological disorders
EP1973407A4 (en) Spiro compounds and methods of use
WO2011009714A3 (en) Benzoquinolizinium salt derivatives as anticancer agents
WO2010121675A3 (en) Thiazolyl-benzimidazoles
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
NZ593797A (en) Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
TW200637860A (en) Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
WO2009138796A3 (en) Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
MX2008013477A (en) Bicyclic tetrahydropyrrole compounds.
WO2008142140A3 (en) Novel 2,3-diamino-quinazolinone derivatives and their medical use
TN2010000390A1 (en) Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease
CU20100175A7 (en) IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE
TN2010000530A1 (en) Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
MX2010009382A (en) Substituted 4-aminocyclohexane derivatives for the treatment of pain.
NZ624621A (en) Manufacturing process for pyrimidine derivatives